Repros Therapeutics Inc. (RPRX)
Symbol Info
Listed Symbol RPRX
Name Repros Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $47,000
Latest Fiscal EPS $-0.70
Price Info
21 Day Moving Average $0.6660
21 Day EMA $0.660930
50 Day Moving Average $0.6118
50 Day EMA $0.616010
200 Day EMA $0.647180
200 Day Moving Average 0.508990
52 Week High $1.32
52 Week Low $0.26
52 Week Change $-45.082000
Alpha -0.004509
Beta 0.6929
Standard Deviation 0.322089
R2 0.003552
Periods 59
Share Information
10 Day Average Volume 251,376
20 Day Average Volume 314,097
30 Day Average Volume 399,785
50 Day Average Volume 764,144
Outstanding Shares 39,560,688
Float Shares 39,059,628
Percent Float 98.73%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 31
Institute Holdings Date 2017-12-31
Institute Bought Previous 3 Months 1,436,357
Institute Holdings Percent 29.400000
Institute Sold Previous 3 Months 344,548
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 501,060
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0074000
21 Day Percent Change 1.12%
30 Day Price Change $0.0060000
30 Day Percent Change 0.90%
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $0.237800
90 Day Percent Change 55.02%
Quarter To Date $0.009900
Quarter To Date Percent 1.50%
180 Day Price Change $0.357000
180 Day Percent Change 114.06%
200 Day Price Change $0.299900
200 Day Percent Change 81.03%
Year To Date $0.009900
Year To Date Percent 1.50%
Profile
Description Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.
Details
Issue Type CS
Market Cap $26,505,661
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding -
CEO
Employees 6
Last Audit UE
Classification
CIK 0000897075
Industry Biotechnology
Sector Healthcare
NAICS Biological Product (except Diagnostic) Manufacturing(325414)
Info
Address 2408 Timberloch Place
Suite B-7
The Woodlands, TX 77380
Website http://www.reprosrx.com
Facisimile +1 281 719-3446
Telephone +1 281 719-3400
Email
Key Ratios
Profitability
EBIT Margin -47,248.3
EBITDA Margin -47,234.5
Pre-Tax Profit Margin -201,679
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $23,000
Revenue Per Share $0.0006
Revenue 3 Years $52.36
Revenue 5 Years $57.75
Valuation Measures
PE Ratio -
Enterprise Value $24,692,660
Price To Sales 1,152.420200
Price To Free Cash -3.1
PE High Last 5 Years -
Price To Book 6.9
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -20.6
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 1.2
Leverage Ratio 86.6
Quick Ratio 0.7
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -183.62
Return On Equity -368.21
Return On Capital -388.38
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
RPRX
Repros The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.